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Most of the pseudocysts secondary to acute pancreatitis resolve spontaneously [6, 7] [2, 8] . Complications include infection, rupture, haemorrhage, biliary compression with or without jaundice, gastrointestinal obstruction, chronic pain, oesophageal varices, leakage with ascites or pleural fluid and pseudoaneurism [8] [9] [10] .
Indications for drainage include: lesions larger than 4 cm or present longer than six weeks, persistent pain, complications and increased volume documented by imaging test [6, 7, 11] .
Complications of surgical treatment occur in 10% to 30%, mortality in 1% to 5% and recurrence in 10% to 20% of the cases [9, 12, 13] .
Percutaneous aspiration is a simple method but associated with frequent recurrence [6, 14] . Percutaneous drainage guided by US or CT is reserved for critically ill patients or for those with infected pseudocyst [15] .
Endoscopic drainage has been reported during the last decade with success rates higher than 80% and can be transmural (cystgastrostomy or cystduodenostomy) or transpapillary [11, 12, 16, 17] . Both can be combined although transpallary drainage should be the first option because it's probably associated with a lower complication rate [18] .
Endoscopic treatment is reported to have lower morbidity than surgery [5] . This There is no consensus in the literature regarding antibiotic use before pseudocyst endoscopic drainage. Some authors [11, 13] recommended its use while others [17, 18] just indicated it when there are evidences of pseudocyst infection. In this study we only prescribed parenteral antibiotics when there were clinical signs of infection and/or positive cultures, or when we were not able to drain the lesion or the bile duct (when biliary stricture was present). Pseudocyst infection was not among our complications. All 6 patients with a positive pseudocyst fluid culture had resolution without recurrence, and if drainage through the stent is effective, pseudocyst infection doesn't seem to interfere with the result of endoscopic treatment, as observed in this study.
Our findings during pancreatograms were similar with those described earlier authors [4, 17, 18] . Several complications of transpapillary drainage have been described and they include: stent occlusion (symptomatic or not), stent proximal or distal migration, pseudocyst infection, pseudocyst recurrence or worsening, pancreatitis, pancreatic ducts inflammatory changes and duodenal erosions [12, [19] [20] [21] . Stent removal or exchange should be done within 4 to 6 weeks due to high occlusion rate after this period [22] , up to 100% after 9 weeks [23] . In our study 3 patients needed stent exchange because of occlusion, but none of them presented any symptoms and those were not considered complications. One patient had a transpapillary stent proximal migration and it was not possible to remove it despite pancreatic sphincterotomy and multiple attempts. He is asymptomatic and without pseudocyst recurrence after a 29 month follow up. Some authors had suggested that such complication doesn't have any clinical consequence [12, 22] . Distal migration is more common, doesn't cause adverse effects and should not be considered as a complication [22] . There was one case of mild pancreatitis that responded to clinical measures as reported earlier [17, 22] .
Pancreatic stents can induce MPD changes like irregularities and strictures, and also changes in secondary branches, similar those changes found in chronic pancreatitis [19, 24] . They may be asymptomatic and reversible with stent removal or exchange. We noticed morphologic changes on pancreatic ducts after transpapillary drainage in 2 cases, and both were asymptomatic and had no recurrence. We should keep in mind remind that such changes can also be part of the natural history of chronic pancreatitis.
Transmural drainage, mainly CG, presents higher risk of complications, specially bleeding [13, 14, 18] . We had 3 complications after CG (bleeding, pneumoperitoneum and stent migration into the pseudocyst) and one after CD (perforation). Asymptomatic pneumoperitoneum was diagnosed one week after the procedure during a routine CT. Possibly, it was due to a small fistula during CG, maybe secondary to the presence of ascites, even though previous CT scan showed that the distance between gastric wall and the pseudocyst was less than lcm [25] [26, 27] . During the study EUS was not available at our institution, and maybe both complications that needed surgery (bleeding and perforation) could be avoided, besides allowing drainage in those cases in which we were unable to identify gastroduodenal compression. More recently we started to perform EUS guided transmural drainage whenever gastric or duodenal wall is not detected during endoscopy [28] . Our success (pseudocyst regression) rate was similar to other published series [12, 14, 17] . There was no difference among different Groups, suggesting that drainage route had no influence on the results.
Our recurrence rate was also comparable to those reported by other authors [11, 14] . The only patient that presented pseudocyst recurrence was treated with another endoscopic drainage, as already described [14, 18] .
Comparative evaluation of abdominal pain score before and after drainage showed statistically significant improvement. Asymptomatic patients were mainly those in alcohol abstinence, and probably this an important factor for good clinical response during long follow up.
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